<b>Piramal Life Sciences net loss of 37cr</b>

Piramal Group's spun-off research and development arm, Piramal Life Sciences today reported a net loss of Rs 37.36 crore for the fourth quarter ended March 31, 2009.

The drug R&D firm had a net profit of Rs 52 lakh in the March quarter of FY'09, Piramal Life Sciences said in a filing to the Bombay Stock Exchange.

The company listed itself on the bourses in May last year. "Since this is the first year of results of the company published subsequent to listing of shares ans as the company has not any operations during the corresponding quarter in the previous year, the figures for previous quarter are not furnished," the filing added.